GE Healthcare Technologies Inc, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joanne Wuensch from Citi maintained a Hold rating on the stock and has a $65.00 price target.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Joanne Wuensch has given his Hold rating due to a combination of factors tied to GE Healthcare’s latest quarter and outlook. The company modestly exceeded revenue expectations, but meaningful margin compression and an earnings shortfall, driven in part by weakness in PCS and a profit hit in PDx, undermined the quality of the beat and signaled execution issues.
At the same time, management cut its 2026 margin outlook and reduced the price target from $80 to $65, reflecting a tougher inflation backdrop and external pressures such as geopolitical tensions. However, steady mid‑single‑digit organic growth guidance, expectations for PCS to improve in the second half, and resolving supply issues in PDx prevent a more negative stance, leaving the shares in a “show‑me” phase that supports a Neutral, or Hold, recommendation.
Wuensch covers the Healthcare sector, focusing on stocks such as Boston Scientific, GE Healthcare Technologies Inc, and Edwards Lifesciences. According to TipRanks, Wuensch has an average return of 0.8% and a 50.00% success rate on recommended stocks.